Patent · US Active

Immunomodulatory polynucleotides and uses thereof

US11326170B2 · kind B2 · utility

0Cited by

17References

37Claims

0Family size

Assignee

Changchun Huapu Biotechnology Co. Ltd. · CN

Inventors

Tao Huang · Changchun, CN
Yan Shao · Andover, US
Jun Zhang · Xiamen, CN

Key dates

Filing date	Apr 17, 2018
Grant date	May 10, 2022
Priority date	—
Expiry date	Dec 8, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are immunomodulatory polynucleotides with sequences of SEQ ID NOs:1-12 which are TLR9 agonists. Therapeutic combinations comprising the immunomodulatory polynucleotides are provided too.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.